Gilead Sciences
GILD
#95
Rank
NZ$314.41 B
Marketcap
NZ$253.39
Share price
2.10%
Change (1 day)
48.75%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$10.83. In 2024 the company made an earnings per share (EPS) of NZ$0.63 a decrease over its 2023 EPS that were of NZ$7.56.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231677.96%
2024NZ$0.63-91.65%
2023NZ$7.5623.98%
2022NZ$6.10-25.86%
2021NZ$8.224850%
2020NZ$0.17-97.64%
2019NZ$7.050.9%
2018NZ$6.9818.71%
2017NZ$5.88-64.88%
2016NZ$16.75-18.45%
2015NZ$20.5455.28%
2014NZ$13.23296.02%
2013NZ$3.3417.89%
2012NZ$2.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.35 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.86-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.25-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.09 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.65 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.26 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.43-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$23.81 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.62 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA